FindTrial
Sign In

A Survey on prevalence of Vitamin B12 deficiency in patients on long time Proton pump inhibitors

A Survey on prevalence of Vitamin B12 Deficiency associated with long term proton pump inhibitors intake

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027092
Enrollment
15000
Registered
2020-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E538- Deficiency of other specified B group vitamins

Interventions

None listed

Sponsors

Eris Lifesciences Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or Female 18 years and above with an intake of PPIs for more than 4 weeks and suggested for the Vitamin B12 testing

Exclusion criteria

Exclusion criteria: 1. No acute systemic illness requiring frequent treatment

Design outcomes

Primary

MeasureTime frame
Prevalence of Vitamin B12 Deficiency associated with long term proton pump inhibitors intake in physician practice.Timepoint: More than 4 week—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactNeha Raval

Eris Lifesciences Ltd.

neha.raval@erislifesciences.com9426133184

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026